Works matching IS 17574676 AND DT 2023 AND VI 15 AND IP 1
Results: 16
Enriched environment enhances β‐adrenergic signaling to prevent microglia inflammation by amyloid‐β.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.15252/emmm.202217061
- By:
- Publication type:
- Article
Repurposing immunosuppressants for antileukemia therapy.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.15252/emmm.202217042
- By:
- Publication type:
- Article
Targeting conformational changes in C‐reactive protein to inhibit pro‐inflammatory actions.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.15252/emmm.202217003
- By:
- Publication type:
- Article
Whole‐brain microscopy reveals distinct temporal and spatial efficacy of anti‐Aβ therapies.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.15252/emmm.202216789
- By:
- Publication type:
- Article
Targeting rare tumors: new focus for clinical research in China.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.15252/emmm.202216415
- By:
- Publication type:
- Article
Artificial sweeteners inhibit multidrug‐resistant pathogen growth and potentiate antibiotic activity.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.15252/emmm.202216397
- By:
- Publication type:
- Article
PGF<sub>2α</sub> facilitates pathological retinal angiogenesis by modulating endothelial FOS‐driven ELR<sup>+</sup>CXC chemokine expression.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.15252/emmm.202216373
- By:
- Publication type:
- Article
Depressive patient‐derived GABA interneurons reveal abnormal neural activity associated with HTR2C.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.15252/emmm.202216364
- By:
- Publication type:
- Article
The genetic regulation of protein expression in cerebrospinal fluid.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.15252/emmm.202216359
- By:
- Publication type:
- Article
Immuno(T)herapy for age‐related diseases.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.15252/emmm.202216301
- By:
- Publication type:
- Article
A novel phosphocholine‐mimetic inhibits a pro‐inflammatory conformational change in C‐reactive protein.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.15252/emmm.202216236
- By:
- Publication type:
- Article
Disease modification and symptom relief in osteoarthritis using a mutated GCP‐2/CXCL6 chemokine.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.15252/emmm.202216218
- By:
- Publication type:
- Article
MiR‐182‐3p targets TRF2 and impairs tumor growth of triple‐negative breast cancer.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.15252/emmm.202216033
- By:
- Publication type:
- Article
IMPDH inhibition activates TLR‐VCAM1 pathway and suppresses the development of MLL‐fusion leukemia.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.15252/emmm.202115631
- By:
- Publication type:
- Article
Advances in high‐throughput mass spectrometry in drug discovery.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.15252/emmm.202114850
- By:
- Publication type:
- Article
X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.15252/emmm.202114557
- By:
- Publication type:
- Article